Olumiant Baricitinib 2mg Tablets

Get a Price/Quote

MOQ : 10 Pieces

Olumiant Baricitinib 2mg Tablets Specification

Pacakaging (Quantity Per Box)
Not clearly legible, refer to pack

Packaging Type
Blister pack

Dosage Form
Tablet

Life Span
Check expiry date on packaging

Origin of Medicine
Imported (manufacturer not specified)

Brand Name
Olumiant

Indication
Rheumatoid Arthritis, other autoimmune conditions as per physician

Salt Composition
Baricitinib 2mg

Drug Type
Allopathic

Ingredients
Baricitinib

Physical Form
Tablet

Function
Janus kinase (JAK) inhibitor, reduces inflammation

Recommended For
Adults with moderate to severe rheumatoid arthritis

Dosage
As prescribed by a physician; commonly 2mg once daily

Dosage Guidelines
Take orally, do not crush or chew, follow doctors advice

Quantity
Not specified on image

Storage Instructions
Store below 30C, protect from moisture and light

Therapeutic Class
Immunosuppressant

Shelf Life
As mentioned on pack; do not use after expiry

Market Availability
Available in Canada, Europe, UK, USA, Australia

Administration Route
Oral

Patient Advice
Consult doctor before use if pregnant, lactating, or having existing health conditions

Prescription Required
Yes

Colour
Film-coated, white tablet

Registration/Approval
Approved by regulatory authorities in multiple countries

Caution
Use under medical supervision; not recommended in patients with severe hepatic impairment or active infections

Olumiant Baricitinib 2mg Tablets Trade Information

Minimum Order Quantity
10 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Pieces Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Olumiant Baricitinib 2mg Tablets About

Olumiant Baricitinib 2mg Tablets are in demand among medical professionals for their masterful efficacy in managing moderate to severe rheumatoid arthritis. These first-rate, film-coated white tablets unlock relief by targeting Janus kinase pathways, reducing inflammation effectively. Available in Canada, Europe, the UK, USA, and Australia, Olumiant must be taken orally as prescribed by a physician. Its excellent track record, regulatory approvals, and prescription control ensure optimal safety for adult patients. Caution is crucial: use only under medical supervision, especially if you have hepatic impairment, active infections, or are pregnant/lactating. Store below 30C, away from moisture.

Extra Features, Clinical Applications & Specific Usage

Olumiant Baricitinib 2mg Tablets offer broad utility across commercial and hospital settings as an advanced immunosuppressant. Designed for adults, these tablets are indicated for rheumatoid arthritis and, as advised, for other autoimmune disorders. Their blister-pack format ensures each dose is protected and fresh. Patients are guided to take the tablet whole, not crushed or chewed, for maximal efficacy. Strict adherence to physician guidance ensures the best therapeutic outcome and minimizes risk of side effects.

Payment Dynamics, Regulatory Approvals & Supply Provisions

The market value of Olumiant is bolstered by its extensive certifications and regulatory approvals across several key regions. Payment terms and outlay options vary and are finalized with the supplier, ensuring flexibility for healthcare providers. With robust transport services, reliable supply chains support consistent product availability. Each batch meets stringent quality standards, and supply ability remains high due to strong manufacturer partnerships and active global distribution routes.

FAQ's of Olumiant Baricitinib 2mg Tablets:

Q: How should Olumiant Baricitinib 2mg Tablets be taken for best results?

A: Olumiant tablets should be taken orally, swallowed whole with water, and exactly as prescribed by your physician. Do not crush or chew the tablet. Always follow your doctor's dosage guidelines for optimal results.

Q: What conditions can Olumiant Baricitinib 2mg Tablets treat?

A: Olumiant is primarily recommended for adults with moderate to severe rheumatoid arthritis, but it may also be prescribed for other autoimmune diseases as determined by your physician.

Q: When should you avoid taking Olumiant Baricitinib?

A: Avoid using Olumiant if you have severe hepatic impairment, active infections, or are pregnant or lactating, unless otherwise directed by a healthcare provider. Always consult your doctor about any pre-existing medical conditions before starting treatment.

Q: Where is Olumiant Baricitinib 2mg commercially available?

A: Olumiant is approved and available in Canada, Europe, the UK, USA, and Australia through prescription-based supply.

Q: What benefits does Olumiant provide as a Janus kinase (JAK) inhibitor?

A: Olumiant delivers relief by inhibiting Janus kinase activity, reducing the inflammation associated with autoimmune conditions, thereby helping patients regain mobility and comfort.